Medical Marijuana, Inc (MJNA)

Dr. Stuart Titus, CEO of Medical Marijuana, Inc., called back in to SmallCapVoice.com to discuss the recent news for the Company. Recently, the Company announced that the Brazilian government has approved its hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) from HempMeds Brasil™ for a fourth indication for import as a prescription medication for the treatment of cancer.

In addition, MJNA announced, that the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product is the first-ever cannabis product (high concentration natural botanical hemp-based cannabidiol (CBD) without THC) approved by federal authorities for import into Mexico, into what projects to be a “$10-12 billion” future cannabis market.

For more about Medical Marijuana Inc. visit visit www.medicalmarijuanainc.com.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.